Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of Cannabigerol against human oral epitheloid carcinoma cells

被引:30
作者
Baek, SH [1 ]
Kim, YO
Kwag, JS
Choi, KE
Jung, WY
Han, DS
机构
[1] Wonkwang Univ, Dept Chem, Iksan 570749, South Korea
[2] Mokpo Jr Coll, Dept Dent Hyg, Mokpo 530730, South Korea
[3] Wonkwang Univ, Dept Oral Anat, Iksan 570749, South Korea
关键词
Cannabinoid; 5-fluorouracil; Cannabigerol; antitumor activity; human oral epitheloid carcinoma cell; MTTassay; SRB assay;
D O I
10.1007/BF02975301
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Geraniol (1), olivetol (2), cannabinoids (3 and 4) and 5-fluorouracil (5) were tested for their growth inhibitory effects against human oral epitheloid carcinoma cell lines (KB) and NIH 3T3 fibroblasts using two different 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and sulforhodamine B protein (SRB) assay. Cannabigerol (3) exhibited the highest growth-inhibitory activity against the cancer cell lines.
引用
收藏
页码:353 / 356
页数:4
相关论文
共 17 条
  • [1] BAEK SH, 1995, B KOR CHEM SOC, V16, P293
  • [2] Synthesis and antitumor activity of cannabigerol
    Baek, SH
    Han, DS
    Yook, CN
    Kim, YC
    Kwak, JS
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 1996, 19 (03) : 228 - 230
  • [3] BAIK KU, 1988, J PHARM SOC KOREA, V32, P125
  • [4] Boersma H. H., 1993, Planta Medica, V59, pA682, DOI 10.1055/s-2006-959964
  • [5] CARMICHAEL J, 1987, CANCER RES, V47, P936
  • [6] DEWEY WL, 1986, PHARMACOL REV, V38, P151
  • [7] SYNTHESIS AND ANTI-MICROBIAL ACTIVITIES OF CERTAIN CANNABICHROMENE AND CANNABIGEROL RELATED-COMPOUNDS
    EISOHLY, HN
    TURNER, CE
    CLARK, AM
    EISOHLY, MA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (12) : 1319 - 1323
  • [8] ACTIVATION OF PHOSPHOLIPASE-A2 BY CANNABINOIDS - LACK OF CORRELATION WITH CNS EFFECTS
    EVANS, AT
    FORMUKONG, E
    EVANS, FJ
    [J]. FEBS LETTERS, 1987, 211 (02): : 119 - 122
  • [9] EVANS AT, 1987, BIOCHEM PHARMACOL, V36, P2037
  • [10] FORMUKONG EA, 1989, J PHARM PHARMACOL, V41, P305